Index Catalog // Hyrax

Remover filtros

Filtragem por: Study Program Molecular Medicine Study Program (MolMed) Sujeito Beta blocker

1. Beta-blocker use and hematopoietic stem cell transplant outcomes

Descrição:: Background: While hematopoietic stem cell transplantation (HSCT) is an effective treatment for hematological malignancies, it is associated with several potential complications. Recent studies have associated beta-blocker (BB) use in critical care...
Data Criada:: August 1-2, 2024